Iris Y Kim1, Éilis J O'Reilly2, Katherine C Hughes2, Xiang Gao2, Michael A Schwarzschild2, Marian T Hannan2, Rebecca A Betensky2, Alberto Ascherio2. 1. From the Departments of Epidemiology (I.Y.K., A.A.), Nutrition (É.J.O., K.C.H., A.A.), and Biostatistics (R.A.B.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (É.J.O.), University College Cork, Ireland; Channing Division of Network Medicine (A.A.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Nutritional Sciences (X.G.), The Pennsylvania State University, University Park; MassGeneral Institute for Neurodegenerative Disease (M.A.S.), Massachusetts General Hospital, Boston; The Institute for Aging Research (M.T.H.), Hebrew Senior Life, Boston; and Department of Medicine (M.T.H.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. iykim@mail.harvard.edu. 2. From the Departments of Epidemiology (I.Y.K., A.A.), Nutrition (É.J.O., K.C.H., A.A.), and Biostatistics (R.A.B.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (É.J.O.), University College Cork, Ireland; Channing Division of Network Medicine (A.A.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Nutritional Sciences (X.G.), The Pennsylvania State University, University Park; MassGeneral Institute for Neurodegenerative Disease (M.A.S.), Massachusetts General Hospital, Boston; The Institute for Aging Research (M.T.H.), Hebrew Senior Life, Boston; and Department of Medicine (M.T.H.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: To prospectively examine how selected lifestyle factors and family history of Parkinson disease (PD) combine to determine overall PD risk. METHODS: We derived risk scores among 69,968 women in the Nurses' Health Study (NHS) (1984-2012) and 45,830 men in the Health Professionals Follow-up Study (HPFS) (1986-2012). Risk scores were computed for each individual based on the following factors previously associated with PD risk: total caffeine intake, smoking, physical activity, and family history of PD for the NHS, and additionally total flavonoid intake and dietary urate index for the HPFS. Hazard ratios were estimated using Cox proportional hazards models. In addition, we performed tests of interactions on both the multiplicative and additive scale between pairs of risk factors. RESULTS: We documented 1,117 incident PD cases during follow-up. The adjusted hazard ratios comparing individuals in the highest category of the reduced risk score to those in the lowest category were 0.33 (95% confidence interval: 0.21, 0.49; ptrend < 0.0001) in the NHS and 0.18 (95% confidence interval: 0.10, 0.32; ptrend < 0.0001) in the HPFS. Results were similar when applying the risk scores computed by summing the predictors weighted by the log of their individual effect sizes on PD risk in these cohorts. Additive interaction was present between no family history of PD and caffeine in men and between caffeine and physical activity in women. CONCLUSIONS: Our results suggest that known protective factors for PD tend to have additive or superadditive effects, so that PD risk is very low in individuals with multiple protective risk factors.
OBJECTIVE: To prospectively examine how selected lifestyle factors and family history of Parkinson disease (PD) combine to determine overall PD risk. METHODS: We derived risk scores among 69,968 women in the Nurses' Health Study (NHS) (1984-2012) and 45,830 men in the Health Professionals Follow-up Study (HPFS) (1986-2012). Risk scores were computed for each individual based on the following factors previously associated with PD risk: total caffeine intake, smoking, physical activity, and family history of PD for the NHS, and additionally total flavonoid intake and dietary urate index for the HPFS. Hazard ratios were estimated using Cox proportional hazards models. In addition, we performed tests of interactions on both the multiplicative and additive scale between pairs of risk factors. RESULTS: We documented 1,117 incident PD cases during follow-up. The adjusted hazard ratios comparing individuals in the highest category of the reduced risk score to those in the lowest category were 0.33 (95% confidence interval: 0.21, 0.49; ptrend < 0.0001) in the NHS and 0.18 (95% confidence interval: 0.10, 0.32; ptrend < 0.0001) in the HPFS. Results were similar when applying the risk scores computed by summing the predictors weighted by the log of their individual effect sizes on PD risk in these cohorts. Additive interaction was present between no family history of PD and caffeine in men and between caffeine and physical activity in women. CONCLUSIONS: Our results suggest that known protective factors for PD tend to have additive or superadditive effects, so that PD risk is very low in individuals with multiple protective risk factors.
Authors: Eilis J O'Reilly; Xiang Gao; Marc G Weisskopf; Honglei Chen; Michael A Schwarzschild; Donna Spiegelman; Alberto Ascherio Journal: Am J Epidemiol Date: 2010-08-02 Impact factor: 4.897
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Albert A Davis; Kristin M Andruska; Bruno A Benitez; Brad A Racette; Joel S Perlmutter; Carlos Cruchaga Journal: Neurobiol Aging Date: 2015-09-30 Impact factor: 4.673
Authors: Daniele Belvisi; Roberta Pellicciari; Andrea Fabbrini; Matteo Costanzo; Sara Pietracupa; Maria De Lucia; Nicola Modugno; Francesca Magrinelli; Carlo Dallocchio; Tommaso Ercoli; Claudio Terravecchia; Alessandra Nicoletti; Paolo Solla; Giovanni Fabbrini; Michele Tinazzi; Alfredo Berardelli; Giovanni Defazio Journal: Neurology Date: 2020-09-17 Impact factor: 9.910
Authors: Philipp Mahlknecht; Kathrin Marini; Mario Werkmann; Werner Poewe; Klaus Seppi Journal: Transl Neurodegener Date: 2022-02-21 Impact factor: 8.014
Authors: Rafael Franco; Rafael Rivas-Santisteban; Irene Reyes-Resina; Gemma Navarro; Eva Martínez-Pinilla Journal: Front Aging Neurosci Date: 2020-03-12 Impact factor: 5.750